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Blood monocytes from patients with sarcoidosis were incubated in vitro, and secretion of endogenous
pyrogen (EP), the protein which mediates fever, and lysozyme (L) were measured. After incubation with
endotoxin, monocytes from 5 patients with sarcoidosis released twice as much EP as did monocytes from
normal individuals (p < .001). Initial 24-hr secretion of L by monocytes from 6 of I I additional patients with
sarcoidosis exceeded the normal range of values for cells from 11 age- and sex-matched control individuals.
Cells with initially augmented secretion rates continued to secrete increased amounts of L for 3 days. A
correlation was noted between in vitro secretion of L by monocytes and serum levels of L in the same patient.
These studies indicate that circulating mononuclear cells in some patients with sarcoidosis have an increased
capacity to secrete EP and/or L prior to tissue localization.
Granulomas in sarcoidosis are morphologically similar to "high-turnover" granu-
lomas produced experimentally [1]. In such models of chronic inflammation, large
numbers of monocytes newly released from bone marrow continuously enter tissues
to participate in granuloma formation [2,3]. Patients with sarcoidosis exhibit a
number of abnormalities which are presumably due to this pathologic stimulation of
the mononuclear phagocyte system (MPS). Serum lysozyme levels are elevated in
most patients with active disease [4]. This enzyme, which hydrolyzes N-acetyl
glucosamine linkages of bacterial cell walls, is present in many secretory and
phagocytic cells throughout the body [5]. High levels in serum or urine, however, are
seen primarily in diseases where production of leukocytes is altered, including
monocytic leukemia [6] and granulomatous diseases [4,7,8]. Monocytes and macro-
phages cultured in vitro secrete lysozyme steadily for many days [9,10].
Fever is a common symptom in certain forms of acute sarcoidosis [11]. Like other
clinical fevers, it is probably due to the action of endogenous pyrogen (EP), a small
protein which is released from stimulated phagocytes in blood and tissues. This
protein in some way alters the function of certain hypothalamic neurons, resulting in
elevation of body temperatures [12]. Both blood monocytes and tissue macrophages
release EP during in vitro incubation, after the cells are stimulated by inflammatory
agents such as endotoxin or phagocytosis [13-16].
Several abnormalities of blood monocyte structure and function in patients with
sarcoidosis have been reported previously [17-20]. These reports raise the possibility
that stimulation of the MPS in sarcoidosis alters the function of monocyte.s early in
their development, even before they leave the blood to evolve into tissue macro-
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All rights of reproduction in any form reserved.phages. In order to further examine monocyte function in this disease, we measured
release of EP and lysozyme from blood mononuclear cells incubated in vitro. The
results of these studies indicate that monocytes from some patients with sarcoidosis
have an increased capacity to secrete EP or lysozyme.
MATERIALS AND METHODS
Pyrogen Studies
All materials, glassware, and reagents were made sterile and pyrogen-free by
standard techniques [14]. Ficoll solution was prepared with sterile pyrogen-free water
and filtered before use through a .45 1Afilter (Nalgene).
Donors: This study was approved by the Committee on Human Investigation at
Yale Medical School. Blood samples were obtained from 5 patients with sarcoidosis,
aged 30 to 48, and 5 healthy medical students. One individual in each group was
studied on two separate occasions; the findings on the repeat study were similar to
those of the first in each case. The diagnosis of sarcoidosis in all patients included
here and below was made using standard clinical criteria and biopsy evidence of non-
caseating granulomata in at least one organ, usually liver. All patients had enlarged
hilar nodes or parenchymal lung disease. Three patients were studied within a few
months of apparent disease onset; two were intermittently febrile, one of whom was
being treated with prednisone. Two patients were considered to have chronic disease,
one of whom was receiving prednisone.
Preparation and incubation of leukocytes: 50-100 ml heparinized blood, for
leukocytes, and 10-20 ml without heparin, for serum, were drawn by venipuncture.
Ficoll-Hypaque technique [21] was used to prepare mononuclear cells. Cell number
was determined using a Coulter particle counter (Model ZF. Coulter Electronics,
Inc., Hialeah, FL), differential smears were made, and cells were suspended in Eagle's
minimum essential medium (MEM: Auto-POW, Flow Laboratories, Inc., Rockville,
MD), with 15% fresh autologous serum, glutamine 2 mM, penicillin 50 U/ml, and
streptomycin 50 pg/ ml. Aliquots of 1.5-2.5 x 107 cells (20-35% monocytes, 65-80%
lymphocytes, 0-4% granulocytes) in 5 ml were then incubated in 30 ml tissue culture
flasks (Falcon Plastics, Div. of BioQuest, Oxnard, CA) at 370 C in 5% C02-air. To
two to four flasks in each experiment 0.1 ml endotoxin, a supernatant prepared from
typhoid vaccine as described previously [13], was added to stimulate EP release.
After 3-4 hours of incubation, supernatant was removed, and fresh media added for
overnight incubation. Media change was repeated at subsequent time intervals, and
all supernatants saved for pyrogen assay. Since initial experiments using cells from
patients as well as control subjects confirmed previous observations [13] that non-
adherent cells, primarily lymphocytes, did not produce EP and that their presence or
absence did not influence EP release by adherent monocytes, in subsequent experi-
ments lymphocytes were not returned to the flasks at the time media were changed. In
all experiments, a control flask of cells incubated without endotoxin was included. In
some experiments, a parallel flask was prepared with cells and heat-killed staphylo-
cocci, to measure pyrogen release after phagocytosis.
Pyrogen assay: Supernatants were prepared for injection by centrifugation at 1,000
g for 20 minutes. They were cultured in thioglycollate broth to confirm sterility, and
stored at 40 C for 1-7 days before assay. Samples with positive cultures were
discarded. In some experiments, at the end of an incubation period cells were
disrupted by freeze-thawing, and cell-associated pyrogen assayed by techniques
described previously [13].
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Techniques for injection and temperature monitoring of rabbits and quantitative
pyrogen assay were as described previously [13]. Briefly, serial twofold dilutions of
each sample were injected into groups of 2-4 rabbits. Dilutions giving temperature
responses which fell on the linear portion of the dose-response curve for monocyte
EP were then used to calculate derived AT, a measure oftotal pyrogen content ofthe
supernatant, for each assay rabbit. Supernatants from different experimental flasks
in any one experiment, such as those with and without endotoxin, but not from
duplicate flasks, were usually injected into the same group of rabbits. Samples from
different experiments were tested in different groups ofanimals, since development of
hypersensitivity fevers made it necessary to use each group of rabbits for only one
week. Assay results are expressed as EP release per 107 monocytes, estimated after
differential counts of 300 cells on Wright's stained cover slips.
Lysozyme Studies
Donors: 30 ml heparinized blood were drawn from 11 patients with sarcoidosis,
and 11 normal donors, matched for age and sex with the patients. Since this study
was conducted separately, only one of the patients from the first study was included
in the second study. Ages ranged from 18 to 50; 5 men and 6 women were included in
each group. Only one of the patients was receiving treatment with prednisone at
the time of the study. Five patients had parenchymal lung disease only, and five
patients had both parenchymal lung disease and hilar adenopathy. One had no
evidence of lung disease at the time ofthe study. Apart from minor skin involvement,
no patients showed clinical evidence ofsystemic disease, although almost all had liver
granulomata on a prior diagnostic liver biopsy. Estimated duration of disease varied
from three months to one year in 5 patients, to over one year in 6 patients. No
patients were hypercalcemic or had elevations of BUN or creatinine. Blood was also
obtained from one patient with a history ofsarcoidosis who was hospitalized for lung
abscess.
Preparation and incubation of leukocytes: Preparation of leukocytes was as
described above for pyrogen studies, except that mononuclear cells were suspended
in MEM-5% heat-inactivated fetal calf serum(MEM-FCS), and incubated overnight
without medium change, and without added endotoxin. Supernatants were then
removed, and fresh media added, consisting of 3 ml MEM with 0.25% w/v
lactalbumin hydrolysate (MEM-lact). Cells were incubated for 24 hours, and the
media change then repeated once more. All supernatants were centrifuged at 1,000 g
for 10 minutes, cultured for sterility, and stored at -20° C for 1-4 weeks.
Lysozyme assay: Supernatants were assayed for lysozyme content by the method
of Gordon, Todd, and Cohn [9], using a cell wall preparation of M. Lysodeikticus
(Difco) and a Gilford spectrophotometer with automatic recorder. 0.2% Triton(final
concentration) was added to all supernatants before assay. Standards of egg white
lysozyme were assayed before and after the experimental samples, and duplicate
samples of supernatants from one patient and one control individual were always
assayed on the same day. Lysozyme content ofeach supernatant was calculated from
the standard curve, and results expressed as lysozyme release per 107 monocytes per
24 hours, based on a differential count of 300 cells. Assays of control fluids (MEM-
FCS, MEM-lact) always measured less than 0.2,ug/ml lysozyme, the lowest level
detected by this assay.
Non-specific esterase stain: Several cover slip smears, prepared for differential
counts, from each of two control individuals and two patients with sarcoidosis were
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non-specific esterase, using the substrate a-napthyl butyrate, to provide a markerfor
monocytes. Parallel smears were stained as usual with Wright's stain.
RESULTS
Pyrogen Studies
Experiments were first done to compare the capacityfor endogenous pyrogen(EP)
release by blood monocytes from patients with sarcoidosis and from normal donors.
Cells were obtained from five individuals in each category; two donors were studied
twice. Endotoxin was added to mononuclear leukocytes, and after an initial 3-4
hours incubation to allow stimulation and adherence of monocytes to the flask
surface, media were changed, and successive incubation supernatants collected at
timed intervals for quantitative pyrogen assay.
The results are shown in Fig. 1. Monocytes from the patients with sarcoidosis
produced twice as much EP as did those from normal individuals duringthefirst 14-
hr incubation (p < .001). Less EP was released during a second 12-hr incubation by
cells in both groups, and the amounts were not significantly different from each
other. Cell-associated pyrogen, measured after both first and second incubation
periods in a number of experiments, was similar to that reported previously[13], and
was the same for cells in both groups. As documented previously[13], and confirmed
in preliminary experiments here, significant EP was not produced by cells in either
group during the first 3-4 hours after addition of endotoxin; non-adherent cells,
predominantly lymphocytes, did not produce EP; and no endotoxin detectable by
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FIG. 1. Cumulative pyrogen release by blood monocytes from 5 patients with sarcoidosis (.--*) and 5 normal
individuals (o - o), incubated with endotoxin. One individual in each group was studied twice. Average maximum
height of fever, ±kS.E.M., is shown corrected for dose and cell number (see Methods) following injection of incubation
medium into rabbits. Numbers of rabbits used for assay are shown in parentheses. Results of6experiments in each group
are presented.
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pyrogen testing was present in any supernatant. Also, cells from patients with
sarcoidosis, like those from normal individuals or febrile patients with other diseases
[23], did not release EP during incubation unless stimulated in vitro by an agent such
as endotoxin. Our results, then, suggest that monocytes from these patients with
sarcoidosis had an enhanced capacity for production and release of EP after
stimulation with endotoxin.
Since it was necessary to use new groups of 4-6 rabbits for pyrogen assays in
different experiments (see Methods), we could not accurately quantitate the EP
produced by any one cell preparation in these studies. However, the measured values
for 3 of the 5 sarcoidosis patients exceeded those for any control individual. Two of
these three patients had had recent onset of disease, and were intermittently febrile;
two were receiving prednisone.
Lysozyme Studies
We next examined the production and release of lysozyme by blood monocytes
from 11 additional patients with sarcoidosis and 11 normal donors, matched for age
and sex with each patient. Blood mononuclear cells from each individual were
incubated in tissue culture flasks, and at 24-hr intervals, flask supernatants were
removed for assay of lysozyme content. Lysozyme release is expressed per 107
monocytes, as estimated from differential counts of 300 cells.
The average values for lysozyme secretion by monocytes from patients with
sarcoidosis and matched controls were 10.1 and 6.8 mg, respectively, for the first 24
hours (see Fig. 2). It is apparent that there is a greater variation among the values in
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FIG. 2. Average lysozyme release ± I standard deviation during the first 24 hours in tissue culture by monocytes
from II patients with sarcoidosis and II control individuals, matched for age and sex. Individual determinations are
indicated by points.the patient group. (The difference in variance, tested by a variance F test, is
significant, F = 4.87, p < .05). The six highest values in the patient group exceed the
95% confidence limits of the control group (mean plus 2 x S.D.), suggestingthat they
are abnormal values; the other five values fall within the range of normal.
In order to determine whether cell populations which demonstrate elevated initial
lysozyme release in vitro continue to produce increased amounts of this enzyme, we
examined values for lysozyme production by such abnormal mononuclear cells
during their second and third days in culture. Data were available for cells from 5 of
the 6 sarcoidosis patients with abnormally high initial values shown in Fig. 2 and for
cells from one patient with tuberculosis (initial lysozyme release = 12.9 p g/ 107
monocytes). Average enzyme release by these cells, compared with that by cells from
11 normal individuals, is shown in Fig. 3. It is apparent that cells with elevated rates
of release initially continued to produce enzyme at rates above those of normal cells.
As expected, cells from patients exhibiting normal lysozyme release initially contin-
ued to release normal amounts during subsequent incubations (not shown).
The mononuclear cell preparations inthese experiments consisted ofboth lympho-
cytes and monocytes; only monocytes, however, produce EP and lysozyme [9,13].
The significance of the data showing differences in production of these compounds
by different mononuclear preparations, therefore, depends on the accuracy of our
differential counts of monocytes. To evaluate this, we compared the percentage of
monocytes estimated from routine Wright's stained differentials with the percentage
of cells staining positively fora-naphthyl butyrase, an esterase present in monocytes
but almost entirely absent from lymphocytes [22]. Several differential smears from
two patients with sarcoidosis and two normal controls were evaluated. The percent-
age of monocytes determined by the two methods agreed closely; average percentage
by Wright's stain was 25 percent and from esterase stain 21 percent. Thus it is
unlikely that inaccuracy inestimating numbers ofmonocytes from differential counts
explains the differences in protein secretion by cells in the different groups.
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FIG. 3. Cumulative average lysozyme release i1 standard deviation by monocytes incubated in vitro for 72
hours. ( - .) Data from monocytes exhibiting increased production during the first 24 hours from 6
patients. (o - o) Data from monocytes of II normal subjects.
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FIG. 4. Correlation between serum lysozyme level and production of lysozyme by monocytes in vitro for 12 patients
with sarcoidosis. Values for the first 24-hr release of lysozyme by monocytes are shown. Bars indicate expected range of
values for normal individuals (mean ± 2 - S.D.).
Correlation with Serum Lysozyme Levels
Serum lysozyme levels are frequently elevated in sarcoidosis [4]. We therefore
examined the relation between the rates of lysozyme secretion by monocytes in vitro
and the levels of serum lysozyme in the same patients. The latter were determined
either at the time of the in vitro study or, in patients with stable disease, within a few
weeks of the in vitro study. The results, shown in Fig. 4, show a significant
correlation between values for monocyte lysozyme secretion duringthe first 24 hours
in culture and the serum lysozyme level in twelve patients (R = 0.66, p = 0.01). It is
apparent that 5 of 6 patients with elevated rates of lysozyme secretion in vitro also
had elevated values of serum lysozyme.
DISCUSSION
Our studies indicate that monocytes from some patients with sarcoidosis have an
increased capacity to secrete certain proteins in vitro. EP, the protein which mediates
fever, is synthesized and secreted by monocytes after stimulation by agents such as
endotoxin or phagocytosis [13-16]. The values for EP production by normal
monocytes reported here agree closely with those reported previously [13]. As noted
in Results, the increased production by patients' cells was apparently not due to
increased levels of intracellular EP, or to abnormal lymphocyte function. A specifi-
cally increased responsiveness of the cells to endotoxin also does not appear to
explain our findings, since in several experiments parallel studies were done with
heat-killed staphylococci, and these gave similar results. Thus, the most likely
explanation of our findings is that monocytes from some patients with sarcoidosis
have an increased capacity to synthesize and secrete EP. However, since in all the
experiments of pyrogen production, cells wereincubated with autologous serum, it is
possible that factors in serum from these patients may have been responsible for the
augmented production of EP.Lysozyme, a hydrolytic enzyme, is synthesized and secreted by blood monocytes
and peritoneal macrophages for weeks[9,10] in culture. Intracellular levels ofenzyme
are very low, and lysozyme production is best measured by assessment of secreted
enzyme [9,10]. These cells apparently require no in vitro stimulus for lysozyme
secretion; enzyme release is not augmented after phagocytosis [9]. Our values for
lysozyme production by normal human monocytes in culture agree well with those
reported previously [9], when note is made of the different protein standards and
numbers of cells used to report the assay results. Since autologous serum was not
included in these incubations, it is unlikely that the observed differences in lysozyme
production were due to serum factors. They were also not due to increased
adhesiveness of monocytes from patients with sarcoidosis, sincefor the first 24 hours
non-adherent cells remained in all flasks. Also, when examined on the second and
third days of incubation, microscopic observations showed no consistent differences
in numbers of healthy, adherent cells in flasks of cells from patients compared with
contror individuals. Since cells with elevated initial rates of release continued to
produce enzyme at increased rates, our data are most consistent with certain cell
populations that have an increased capacity for synthesis and secretion of this
protein. Because the studies of pyrogen and lysozyme production reported here were
conducted separately, we have no information on the production ofboth proteins by
cells from a single patient or control individual.
Although abnormalities of lymphocyte function have been repeatedly demon-
strated in sarcoidosis [24], there have been few studies of mononuclear phagocyte
function. Two investigators have reported that increased numbers of monocytes
migrate into sites of skin abrasions and attach to coverslips within a few hours
[17,18]; typical giant cells were also reported to develop subsequently [18]. Mono-
cytes from patients with sarcoidosis showed enhanced phagocytic capacity for latex
as well as IgG and complement-coated erythrocytes [19]. Increased levels off -
glucuronidase, as determined by cytochemical staining, have also been noted in cells
from such patients [20]. It is of interest that similarly enhanced migratory, phago-
cytic, and enzymatic function of monocytes characterize "activated" mononuclear
phagocytes [25] studied in many experimental models. As originally described, these
cells develop altered function as a result of specific immunologic stimulation. Such
phagocytes also exhibit enhanced bactericidal capacity. Although blood monocytes
from patients with tuberculosis show enhanced killing of staphylococci [26], to our
knowledge similar studies have not been done with monocytes from patients with
sarcoidosis. We did not include patients with other diseases in our studies, so we do
not know whether the secretory abnormalities we noted are specific for sarcoidosis.
In a recent study [27], increased monocytopoiesis and high tissue turnover of
macrophages was described in cases of active tuberculosis, but not in 4 of 6 patients
with sarcoidosis. The variable clinical syndromes in this latterdisease, however, make
comparisons between small numbers ofpatients difficult. Other authors, infact, have
compared sarcoidosis with experimental models of"high-turnover" granulomas [1],
situations in which monocyte production and entry into tissues are accelerated [2].
Such enhanced production would probably alter the state of maturation of blood
monocytes, or lead to recirculation of tissue macrophages. There is no reliable
information about the relative capacity for EP or lysozyme production by mononu-
clear phagocytes at different stages of maturation. Although mouse macrophages
produce larger amounts oflysozyme in vitro than do human monocytes [9], no such
comparisons have been made between these two cell types in the same species.
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Preliminary ultrastructural examination of cells from three patients in our studies
failed to identify monocytes with definite morphologic abnormalities, or recirculating
macrophages or promonocytes (Bodel, P. and Bainton, D.F., unpublished observa-
tions).
Finally, we observed a correlation between in vitro secretion of lysozyme by
monocytes and serum lysozyme levels (Fig. 4). However, the relation of these values
to the clinical status of the patients was uncertain, since the "activity" as well as
extent of sarcoidosis was usually difficult to determine. When renal disease and
hypercalcemia are absent, earlier work indicated that levels of serum lysozyme
correlate fairly well with the extent of tissue involvement by granulomas [4]. This
aspect of the biochemical assessment ofsarcoidosis has been reviewed elsewhere[28].
Our findings thus suggest that monocytes from patients with multiple granulomata
show enhanced secretory activity even before theylocalize in tissues as macrophages.
Such altered function ofblood monocytes may be related to the rapid production and
turnover of mononuclear phagocytes which is postulated to occur in sarcoidosis [1].
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